PUBLIC CONTRACT · 2017
Aquisição de Infliximab – sujeito à concorrência (P259-AC-2017-123)
- Contract value
- €62,837.14
- Signed on
- 29 September 2017
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3818780PUBLISHED DESCRIPTION
07/00067.11/2017 - Aquisição de Infliximab – sujeito à concorrência (P259-AC-2017-123) - Compras Centralizadas ano 2017
Parties involved
- Place of performance
- Portugal, Aveiro, Santa Maria da Feira
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Laboratório Pfizer, Lda · Tax ID 500162166
Values and timeline
- Contract price
- €62,837.14
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 25 October 2017
- Award date
- 27 September 2017
- Signing date
- 29 September 2017
- Performance period
- 94 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- CP 2015/6 - Acordo quadro para o fornecimento de Medicamentos do Foro Oncológico
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2978881
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.